Publication – 2014
This white paper offers guidance in three areas. First, it covers general safety and quality, including procedures; roles and qualification for the members of the brachytherapy team; source radionuclides, and types of reported medical events. Next, the document looks at clinical applications for HDR brachytherapy by disease site, including intraluminal and intraoperative brachytherapy. Finally, it discusses key measures to avoid catastrophic failures.
Read executive summary.Read full statement.
Resources Value of MRI without/with applicator in place for target definition in cervix cancer brachytherapyAdvancements in Clinical BrachytherapyASTRO’s Brachytherapy Model Policy
Author SocietyAmerican Society for Radiation Oncology
EndorsementsAmerican Association of Physicists in MedicineAmerican Association of Medical DosimetristsAmerican Society of Radiologic TechnologistAmerican Brachytherapy Society
ASTRO guidelines present scientific, health, and safety information and may reflect scientific or medical opinion. They are available to ASTRO members and the public for educational and informational purposes only. Commercial use of any content in this guideline without the prior written consent of ASTRO is strictly prohibited.